Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice - Results of the Non-Interventional DETECT Study.
Plate T, Friedrich FW, Beier J. Plate T, et al. Among authors: beier j. Int J Chron Obstruct Pulmon Dis. 2020 Jun 10;15:1335-1347. doi: 10.2147/COPD.S252354. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32606643 Free PMC article. Clinical Trial.
Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study.
Beeh KM, Kirsten AM, Tanase AM, Richard A, Cao W, Hederer B, Beier J, Kornmann O, van Zyl-Smit RN. Beeh KM, et al. Among authors: beier j. Int J Chron Obstruct Pulmon Dis. 2018 Dec 6;13:3923-3936. doi: 10.2147/COPD.S179293. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30584293 Free PMC article. Clinical Trial.
Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients.
Beier J, van Noord J, Deans A, Brooks J, Maden C, Baggen S, Mehta R, Cahn A. Beier J, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:153-64. doi: 10.2147/COPD.S26100. Epub 2012 Mar 5. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 22419863 Free PMC article. Clinical Trial.
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM, Beier J, Candler H, Wittig T. Beeh KM, et al. Among authors: beier j. Int J Chron Obstruct Pulmon Dis. 2016 Nov 23;11:2877-2884. doi: 10.2147/COPD.S117652. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27920515 Free PMC article. Clinical Trial.
754 results